DaVita Stock Sees Rising Relative Strength

Novavax and Palantir rocket higher, while PayPal slumps and other stocks on the move

DaVita Is the S&P 500’s Top Gainer. Here’s Why the Dialysis Stock Is Surging.

DaVita Is the S&P 500's Top Gainer. Why the Dialysis Stock Is Surging.

Stock Market News

DaVita 1Q Rev $2.87B >DVA

Aerospace Executives Go to Trial Over Alleged No-Poach Deals

Junk Bonds Rally on Hopes Inflation Has Peaked

Unprofitable public companies gambled more than $200 million in California, and lost big

Dialysis company DaVita stock suffered worst day in 22 years after big profit miss, disappointing outlook

DaVita Stock Plummets Most Since 2000 on Outlook Cut

DaVita stock falls as higher wages, missed treatments push earnings below Street expectations

First Criminal Wage-Fixing Trials End in Loss for DOJ

Not Sure How Much You Should Be Paid? Colorado Could Offer Some Clues

Active Funds Are Doing Better. This Is What's Helping Them.

DaVita and its former CEO indicted, Justice Department charges illegal 'no poaching' deals with rivals